Is the COVID-19 pandemic magnifying disparities in stroke treatment?

Regenhardt, Robert W; Young, Michael J; Leslie-Mazwi, Thabele M

Regenhardt, Robert W; Young, Michael J; Leslie-Mazwi, Thabele M.

Regenhardt RW; Neurology and Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA robert.regenhardt@mgh.harvard.edu.
Young MJ; Neurology and Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Leslie-Mazwi TM; Neurology and Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.

J Neurointerv Surg ; 13(4): 299-300, 2021 04.

Article in English | MEDLINE | ID: covidwho-1088284

Subject(s)

COVID-19; Stroke; Black or African American; Humans; Pandemics; SARS-CoV-2; Stroke/epidemiology; Stroke/therapy; Thrombectomy

Keywords

COVID-19; stroke; thrombectomy

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Stroke / COVID-19 Type of study: Observational study Limits: Humans Language: English Journal: J Neurointerv Surg Year: 2021 Document Type: Article Affiliation country: Neurintsurg-2021-017292

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google